| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 06/06/2012 | EP1568775B1 Cancer-associated gene |
| 06/06/2012 | EP1548024B1 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof |
| 06/06/2012 | DE102010062288A1 Verwendung von Zytokine-freisetzenden, biodegradierbaren Partikeln in Hyaluronsäure zur Behandlung von Knorpeldefekten, insbesondere von Osteoarthrose Use of cytokine release, biodegradable particles in hyaluronic acid for the treatment of cartilage defects, particularly osteoarthritis |
| 06/06/2012 | CN1935839B Analogues of GLP-1 |
| 06/06/2012 | CN1561343B Soluble T cell receptor |
| 06/06/2012 | CN102485903A Method for preparing biological active protein oligopeptide powder from deer placenta |
| 06/06/2012 | CN102485748A Oligopeptides with targeting thrombolytic activity, preparation method thereof, and application thereof |
| 06/06/2012 | CN102485747A Oligopeptides with targeting thrombolytic activity, preparation method and application thereof |
| 06/06/2012 | CN102485746A Oligopeptides having target-oriented thrombolytic activity and their preparation method and application |
| 06/06/2012 | CN102485745A Thrombolytic oligopeptides, preparation method and application thereof |
| 06/06/2012 | CN102485744A Thrombolytic oligopeptide compound, its preparation method and application |
| 06/06/2012 | CN102485743A Antineoplastic compound |
| 06/06/2012 | CN102485272A Application of recombinant human Prx-6 protein in treating burns and scalds |
| 06/06/2012 | CN102485214A High-entrapment efficiency long-acting nerve growth factor liposome and preparation method thereof |
| 06/06/2012 | CN101979652B Mactra quadrangularis protein polypeptide with antioxidant activity and preparation method and application thereof |
| 06/06/2012 | CN101940785B Hydrogen sulfide-producing enzyme preparation and use thereof |
| 06/06/2012 | CN101921741B Relative protein for resisting against prawn white spot syndrome viruses (WSSV), characteristic sequence and application thereof |
| 06/06/2012 | CN101863965B Helicobacter pylori urease B antigenic epitope polypeptide and application thereof |
| 06/06/2012 | CN101856495B Medical composition and mixture for treating chicken infectious bursal disease and preparation method thereof |
| 06/06/2012 | CN101785856B Stably isoosmotic desmoteplase alpha1 or mutant preparation thereof |
| 06/06/2012 | CN101748110B Desmoteplase alpha 1 mutant |
| 06/06/2012 | CN101705241B Method for preparing recombined blue algae antiviral protein and application thereof |
| 06/06/2012 | CN101648008B Compound preparation used for joint care and preparation method thereof |
| 06/06/2012 | CN101544693B Recombined extrasin alpha 1 two-strand body protein and preparation method thereof |
| 06/06/2012 | CN101507822B Reduction of dermal scarring |
| 06/06/2012 | CN101228183B Method of purifying APO-2 ligand/TRAIL using crystallisation in the cold |
| 06/06/2012 | CN101190942B Compound with thrombus dissolving activity and its preparation method and application |
| 06/06/2012 | CN101190940B Polypeptide with target antithrombotic activity and its preparation method and application |
| 06/06/2012 | CN101062405B Medicine for animals for treating and preventing avian influenza |
| 06/05/2012 | US8193415 Plant expressing mammalian β1,4-galactosyltransferase and β1,3-glucuronyltransferase |
| 06/05/2012 | US8193410 Transgenic plants with controlled distribution of a trait to progeny |
| 06/05/2012 | US8193367 Polymorph of a pharmaceutical |
| 06/05/2012 | US8193332 Cancer cell-specific apoptosis-inducing agents that target chromosome stabilization-associated genes |
| 06/05/2012 | US8193326 Nucleotide sequences coding oncogenic polypeptides for use in generating vaccines to prevent and treat cell proliferative disorders; genetic vaccines |
| 06/05/2012 | US8193323 mpl ligand (thrombopoietin), active fragments thereof, and fusion proteins and compositions comprising mpl ligand and other cytokines |
| 06/05/2012 | US8193317 Freeze-dried fibrin matrices and methods for preparation thereof |
| 06/05/2012 | US8193313 Methods and compositions for tumor vaccination and therapy |
| 06/05/2012 | US8193312 Bone morphogenic protein binding peptide |
| 06/05/2012 | US8193311 CD44 polypeptides, polynucleotides encoding same, antibodies directed thereagainst and method of using same for diagnosing and treating inflammatory diseases |
| 06/05/2012 | US8193310 Alpha helical mimics, their uses and methods for their production |
| 06/05/2012 | US8193309 Compositions and methods for preventing or treating cancer |
| 06/05/2012 | US8193185 Administering a tryptanthrin compound, e.g., 8-nitroindolo[2,1-b]quinazoline-6,12-dione, to potentiate the immune response to an antigen; immunostimulants; small molecule immune potentiators; immunotherapy for infectious diseases; anticarcinogenic agents; vaccine adjuvant compositions and kits |
| 06/05/2012 | US8193163 Compositions and methods for siRNA inhibition of ICAM-1 |
| 06/05/2012 | US8193162 Human liver regeneration associated protein and the use thereof |
| 06/05/2012 | US8193157 Antiviral therapies |
| 06/05/2012 | US8193156 Dipeptides incorporating selenoamino acids with enhanced bioavailability—synthesis, pharmaceutical and cosmeceutical applications thereof |
| 06/05/2012 | US8193155 Method and compositions for treating skin |
| 06/05/2012 | US8193154 Oligopeptide tyrosinase inhibitors and uses thereof |
| 06/05/2012 | US8193153 Trophic factor for the treatment of retinal degenerative diseases |
| 06/05/2012 | US8193152 Treatment or prevention of hemorrhagic viral infections with immunomodulator compounds |
| 06/05/2012 | US8193151 Methods for treating atrial or ventricular arrhythmias |
| 06/05/2012 | US8193150 Improving vascular function with an inactivating mutant of a TRPC channel protein |
| 06/05/2012 | US8193149 Use of Peptide YY, alone or in combination with glucagon-like peptide, for use in medicine |
| 06/05/2012 | US8193148 Short fatty acid tail polymyxin derivatives and uses thereof |
| 06/05/2012 | US8193147 Use of copolymer 1 for treatment of muscular dystrophy |
| 06/05/2012 | US8193146 Method of ameliorating symptom caused by mood disturbance |
| 06/05/2012 | US8192990 Buffer solution for electroporation and a method comprising the use of the same |
| 06/05/2012 | US8192975 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith |
| 06/05/2012 | US8192957 Fibrillation-resistant insulin and insulin analogues |
| 06/05/2012 | US8192955 Nucleic acids encoding MPL ligand (thrombopoietin), variants, and fragments thereof |
| 06/05/2012 | US8192953 Comprising tetranectin trimerising structural element (TTSE) capable of forming a stable complex with two other TTSEs; stability; used as a carrier of other chemical entities; drug delivery |
| 06/05/2012 | US8192935 Methods for assessing cisplatin resistance, disease progression, and treatment efficacy in ovarian cancer as related to MetAP2 expression |
| 06/05/2012 | US8192769 Protein hydrolysate and plant sterol containing composition for improving serum lipid profile and preventing atherosclerosis |
| 06/05/2012 | US8192763 Processed ECM materials with enhanced component profiles |
| 06/05/2012 | US8192753 pH-sensitive cationic lipids, and liposomes and nanocapsules containing the same |
| 06/05/2012 | US8192744 Drug for treating states related to the inhibition of angiogenesis and/or endothelial cell proliferation |
| 06/05/2012 | US8192743 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
| 06/05/2012 | US8192736 Remedy for endometriosis |
| 06/05/2012 | US8192735 Method for modulating appetite |
| 06/05/2012 | US8192734 Compositions and methods for bone strengthening |
| 06/05/2012 | US8192732 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 06/05/2012 | US8192719 Methods and kits to diagnose growth hormone deficiency by oral administration of EP 1572 or EP 1573 compounds |
| 06/05/2012 | CA2519787C Methods of treating diabetes by blocking vegf-mediated activity |
| 06/05/2012 | CA2507530C Rapamycin and il-10 for the treatment of immune diseases |
| 06/05/2012 | CA2446439C .delta.4-desaturase genes and uses thereof |
| 06/05/2012 | CA2435375C Mammalian tumor susceptibility gene products and their uses |
| 06/05/2012 | CA2431207C Compositions containing inclusion complexes |
| 06/05/2012 | CA2426765C Genomes participating in rheumatoid arthritis, method of the diagnosis thereof, method of evaluating the onset possibility thereof, diagnostic kit for detecting them and therapeutic method and remedies for rheumatoid arthritis |
| 06/05/2012 | CA2418238C Method for treating unstable angina pectoris |
| 06/05/2012 | CA2368670C Modulation of vascular permeability by means of tie2 receptor activators |
| 06/05/2012 | CA2324226C Inhibitors of caspases |
| 06/05/2012 | CA2292882C Mutant having uracil phosphoribosyl transferase activity |
| 06/05/2012 | CA2286575C Sustained-release compositions and method for preparing same |
| 06/05/2012 | CA2264939C Materials and methods relating to the diagnosis and treatment of pre-eclampsia and diabetes |
| 06/05/2012 | CA2249352C Immunoliposomes that optimize internalization into target cells |
| 06/05/2012 | CA2248667C Hla-a2.1 binding peptides and their uses |
| 06/05/2012 | CA2233534C Manipulation of non-terminally differentiated cells using the notch pathway |
| 05/31/2012 | WO2012071561A2 Anti-il-6 antibodies for the treatment of anemia |
| 05/31/2012 | WO2012071554A2 Anti-il-6 antibodies for the treatment of oral mucositis |
| 05/31/2012 | WO2012071527A2 Protein delivery from stem cell microcarriers |
| 05/31/2012 | WO2012071521A2 Adjuvant |
| 05/31/2012 | WO2012071420A1 Enzyme combinations to reduce brain tissue swelling |
| 05/31/2012 | WO2012071042A1 Compositions and methods for treating or preventing lupus |
| 05/31/2012 | WO2012070975A1 Modified peptides with antiviral properties and method for the production thereof |
| 05/31/2012 | WO2012070973A1 Method for treating cancer patients |
| 05/31/2012 | WO2012070972A1 Method for treating cardiovascular disease patients |
| 05/31/2012 | WO2012070971A1 Cosmetic and pharmaceutical composition for rejuvenating and regenerating the skin, inter alia after surgical operations |
| 05/31/2012 | WO2012070966A1 Modified oligopeptides for treating pancreatitis, gastric ulcers and other hyperenzymemias based on a peptidic enzyme inhibitor and method for producing said modified oligopeptides |
| 05/31/2012 | WO2012070964A1 Modified oligopeptides with anticancer properties and method for producing same |
| 05/31/2012 | WO2012070554A1 Peptide |